Share Name Share Symbol Market Type Share ISIN Share Description
Woodford Patient Capital Trust Plc LSE:WPCT London Ordinary Share GB00BVG1CF25 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 33.60 33.55 33.90 0.00 0.00 - 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 0.0 -3.8 -0.5 - 305

Woodford Patient Capital Share Discussion Threads

Showing 10226 to 10246 of 11725 messages
Chat Pages: Latest  421  420  419  418  417  416  415  414  413  412  411  410  Older
DateSubjectAuthorDiscuss
01/9/2019
11:01
Yet another deluded commentary. The under-performance has been due to two things: 1. Neil's ability to pick awful companies; and 2. The value style is being trounced by momentum. In my view 1. >> 2. in terms of the rationale, but 1. is ignored. "The portfolio delivered a disappointingly negative return during the period under review, in conditions which remained unfavourable for our disciplined, valuation-oriented investment approach. Conversely, the broader UK stock market delivered a robust double-digit return during the period, with leadership – as has been the case for much of the last three years – coming from oil, mining and other large global-facing companies. These conditions have all the hallmarks of a momentum-driven market. Momentum investing involves buying assets when they have risen in price and selling assets when the price has fallen, with little or no regard paid to the fundamental value of those assets. It is the anti-thesis of our fundamentally-anchored investment approach which will, as a result, tend to under- perform in such conditions. In the UK, this momentum has manifested itself in a narrow fixation on businesses that are seen as beneficiaries of a reflationary global growth scenario that we simply did not (and do not) believe in. It has come despite increasing evidence of problems in many emerging market economies, most prominently, China. The fund has very little exposure to these parts of the market because of macroeconomic concerns and on valuation grounds. This lack of exposure to sectors such as Basic Materials, Oil & Gas, Consumer Goods and large financial groups such as HSBC, explains a significant proportion of the fund’s under-performance. Instead, the portfolio has been biased towards the few areas of the market which continue to offer valuation appeal. This has resulted in a meaningful exposure to domestically-focused businesses, which have been left behind in the late-stage bull market conditions that have prevailed, and therefore represent the most attractively valued stocks in our investment universe. Nevertheless, this positioning proved unhelpful during the period, with continued Brexit uncertainty weighing on the share prices of many business that have a reasonable exposure to the UK, irrespective of their starting valuations. This explains a further part of the portfolio’s underperformance during the period, with negative contributions from the likes of Provident Financial, Redde and Eddie Stobart Logistics. Meanwhile, we also saw a negative contribution from some of the portfolio’s earlier-stage healthcare stocks, including Autolus, Circassia and Mereo Biopharma. Here too, share price weakness was not fundamentally-driven. Indeed, each of these three businesses delivered meaningfully positive operational progress during the period under review, but this was not enough to prevent their share prices from declining in a market environment which remains hostile towards this sort of investment opportunity. More positively, some of the portfolio’s exposure to UK housebuilding started to perform well for the portfolio, including Barratt Developments and Taylor Wimpey. We also saw bids for BCA Marketplace and Nightstar Therapeutics during the period. There are many ways through which under-valuation can ultimately be realised, and corporate activity is one of them. We would expect to see more bids going forward."
topvest
31/8/2019
11:57
This guy flip-flops more than buyunwell! careful - 29 Jul 2019 9161 of 10065 irresistible market price 51.5p discount 36%. just bought in again. I have a good record here and a nose for a bargain. careful - 31 Jul 2019 - 9273 of 10065 Many understand the cold fusion scam. This was exposed as bunk decades ago. how could anyone fall for the same scam again? careful - 09 Aug 2019 - 9612 of 10065 how quiet this thread goes when WPCT rises by 6%. maybe NW is a genius after all, just a brief spell in the wilderness that now seems to be over. careful - 27 Aug 2019 - 9975 of 10065 Are there any investments in this trust that have done well? This clown Woodford has been exposed as the worst ever professional investor. careful - 30 Aug 2019 - 10055 of 10065 This seems to have turned the corner. Maybe NW was right all along. We have not been patient enough.
daffyjones
30/8/2019
20:44
“Careful must be on medication” - Orinocor. So why hasn’t he been taking it?
chucko1
30/8/2019
19:46
Just been reading the pathetic WIM comment about how they didn't value the unlisteds (re IH revalation). Er, except Woody largely did, by dint of taking part in later, smaller, much higher-priced funding rounds.
spectoacc
30/8/2019
17:29
They have turned a corner,....unfortunately around the corner is another very steep road and Woody’s brakes are on the blink!
topvest
30/8/2019
14:38
Had a look at OPTI mentioned above. Stockpedia gives it a rank of 2, a "sucker stock". In other words, utter bilge.
blippy3
30/8/2019
14:04
Now to Charon must they bow And ask to cross the Stygian ford But Charon won't have them as they can't pay. Woody's taken all their money away.
jonwig
30/8/2019
13:52
Like Icarus did Woodward fly Alas too close, too close To Helios’ burning brow All investors did heave a sigh Now to Charon must they bow And ask to cross the Stygian ford
volsung
30/8/2019
13:27
careful must be on medication
orinocor
30/8/2019
13:15
If upon this basis, I am not surprised that you would be confused about Careful’s post #10055: careful - 27 Aug 2019 - 09:32:04 - 9975 of 10057 ::: WOODFORD PATIENT CAPITAL TRUST ::: - WPCT Are there any investments in this trust that have done well? This clown Woodford has been exposed as the worst ever professional investor. He got lucky in the past, he did the right thing, no doubt for the wrong reasons. With WPCT he probably felt important going round to start up companies in need of cash to pursue their crazy ideas, and fell for the fancy projections and overhead presentations. He had more cash to place than he knew what to do with. Every one a dud. ———;——̵2;——R12;——212;—————- That would be one stonking great corner to turn.
chucko1
30/8/2019
10:59
Careful, "turned the corner"? On what basis do you make that statement?
andy
30/8/2019
08:18
This seems to have turned the corner. Maybe NW was right all along. We have not been patient enough.
careful
30/8/2019
08:16
Isn’t it one of TW “nifty 50”. I don’t subscribe, but looking at the headlines below it appears to be. Again, I could be wrong.
dr biotech
30/8/2019
08:03
jonwig, Yes, meeting and engaging with management can be illuminating, and also very risky if the guy running the company is a good salesman.....
andy
30/8/2019
08:00
...And open to Fat Bloke Finance bias. One thing to say about the market - it catches the shysters in the end.
spectoacc
30/8/2019
07:57
Andy - both TW and NW are believers in "meeting management", hence TW's OPTI tip. This leaves them open to being manipulated.
jonwig
30/8/2019
07:53
jonwig, Funny you should say that, I was thinking the other day that perhaps shorting everything TW tips, regardless of whether he's bullish or bearish on a stock, would turn out to be quite profitable.
andy
30/8/2019
07:43
TW hasn't mentioned Shoezone on SPs - at least a search throws up nothing. He is currently tipping Optibiotix [OPTI] to buy. Comments on his most recent OPTI tip suggest his readers are sceptical about his 'buy' tips. Basically, if he says it's a dog it sure is a dog. But if he says it's a tiger, it's probably a dog too!
jonwig
30/8/2019
07:07
"Delusional" is a word I've long used for Woody - that quote seems to confirm it.
spectoacc
30/8/2019
06:52
hxxps://citywire.co.uk/funds-insider/news/link-defends-handling-of-woodford-fund-suspension/a1263108 From the article lol 'We operate to look after investors in that role and I think we've done that well,' he said.
ak47high
30/8/2019
06:32
Amusing how Woody's gone from full disclosure (good on him) to just about no disclosure at all (ridiculous). The main thing I want to know is what he's punted the c.£800m on - allegedly "Liquid UK-focussed FTSE100 stocks", aka LLOY? Or more housebuilders? Either way, had they done well, I've no doubt they'd be being disclosed, since the things he has to sell are perfectly well known already. (@RCT2 - not necessarily in the US, where passive has become massive. Arguably the more passive skews, the more opportunity for trading, and the less passive skews).
spectoacc
Chat Pages: Latest  421  420  419  418  417  416  415  414  413  412  411  410  Older
Your Recent History
LSE
WPCT
Woodford P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200224 10:12:13